GPC3-CAR-T

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS
EP 3707160 A1Applicant: THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICESPriority: 2017
CN
EP
US
WO
7 publications
GPC3 CAR-T CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
EP 4121516 A4Applicant: EUTILEX CO LTDPriority: 2020
CN
EP
US
WO
5 publications
ORTHOGONAL GPC3 CHIMERIC ANTIGEN RECEPTOR T CELLS
EP 4490174 A4Applicant: SYNTHEKINE INCPriority: 2022
CN
EP
US
WO
4 publications
CANCER VACCINE USING COMMON CANCER ANTIGEN COCKTAIL, TCR/CAR-T CELL THERAPEUTIC, COMPANION DIAGNOSTIC METHOD, AND METHOD FOR DIAGNOSING CANCER ONSET RISK BY BLOOD-CIRCULATING CANCER CELL DETECTION
EP 4527406 A1Applicant: NAT CANCER CTPriority: 2022
CN
EP
US
WO
4 publications
CHIMERIC ANTIGEN RECEPTOR TARGETING GPC-3 AND IMMUNE CELLS EXPRESSING SUCH FOR THERAPEUTIC USES
EP 4547718 A1Applicant: CRISPR THERAPEUTICS AGPriority: 2022
CN
EP
US
WO
4 publications
COMPOSITIONS AND METHODS REGARDING ENGINEERED AND NON-ENGINEERED GAMMA-DELTA -T CELLS FOR TREATMENT OF SOLID TUMORS
EP 3860716 A2Applicant: ADICET BIO INCPriority: 2018
CN
EP
US
4 publications
USE OF GPC3 AND GPC3-CAR-T IN DIAGNOSIS AND TREATMENT FOR IDIOPATHIC PULMONARY FIBROSIS
WO 2024207679 A1Applicant: RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINEPriority: 2023
CN
WO
3 publications
GPC3 CAR- T CELLS SECRETING IL-18 AND METHODS OF MAKING AND USING THE SAME
US 2023151113 A1Applicant: EUTILEX CO LTDPriority: 2020
CN
US
2 publications
Anti-GPC3 antibody, anti-GPC3 chimeric antigen receptor and GPC3/CD3 bispecific antibody
US 12492252 B2Applicant: SHANDONG BOAN BIOTECHNOLOGY CO LTDPriority: 2020
CN
US
2 publications
GENE-EDITED NATURAL KILLER CELLS
US 20260250634 A1Applicant: CRISPR THERAPEUTICS AGPriority: 2022
US
WO
2 publications

Drugs